GRAIL, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from GRAIL, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 165% in 3 years; of every extra $100 of sales, $5,447 became extra profit. Higher than almost all Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $37 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-77.5×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 79% of Healthcare companies in United States.
Cash Locked Ratio
$22For every $100 of sales, $22 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $40 tied up three years earlier.
Less money tied up than 54% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$5,447Sales grew 165% in 3 years; of every extra $100 of sales, $5,447 became extra profit.
Higher than almost all Healthcare companies in United States.
Asset Productivity Ratio
+165% / -41%In 3 years sales changed by +165% while total assets changed by -41%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-25.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 60% of Healthcare companies in United States.
Cash Cushion Ratio
+15%Cash, after subtracting all debt, equals 15% of its market value (net cash).
Higher than 57% of Healthcare companies in United States.
Tangible Assets Ratio
37%Of every $100 the company owns, $37 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 91% of Healthcare companies in United States.
Tangible Net Worth Ratio
28%Of every $100 of net worth, $28 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 62% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
GRAIL, Inc. made a loss over the last year. GRAIL, Inc. owes $0.11 for every $1 it owns. GRAIL, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossGRAIL, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.23The share price is 2.23 times GRAIL, Inc.'s book value per share, lower than 54% of Healthcare companies in United States.
Market cap
$5.7 BThe total market value of all of GRAIL, Inc.'s shares at today's price (share price × number of shares), larger than 86% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$2.5 BWhat GRAIL, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$56.93Net worth divided by the number of shares. The share price of $127.06 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
-16.1%GRAIL, Inc. lost 16.1% of its shareholders' money over the last year, higher than 68% of Healthcare companies in United States.
Owes vs Owns
0.11×GRAIL, Inc. owes $0.11 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Dividend yield
NoneGRAIL, Inc. does not currently pay a dividend.
Revenue growth
+17%Revenue rose 17% in the year to Dec 2025, and grew 38% a year on average over 3 years.
Profit growth
LossGRAIL, Inc. made a loss in each of the last two years.
Profit margin
-277.5%GRAIL, Inc. lost $277 for every $100 of revenue.
Cash vs debt
Net cashGRAIL, Inc. held $850 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For GRAIL, Inc.: $5.7 B ÷ $2.5 B (30 Jun 2026) = 2.2.
What is GRAIL, Inc.'s return on equity?
GRAIL, Inc. lost 16.1% of its shareholders' money over the last year, higher than 68% of Healthcare companies in United States.
How much does GRAIL, Inc. owe compared with what it owns?
GRAIL, Inc. owes $0.11 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Does GRAIL, Inc. pay a dividend?
No. GRAIL, Inc. does not currently pay a dividend.
Is GRAIL, Inc.'s revenue growing?
Revenue rose 17% in the year to Dec 2025, and grew 38% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.